The American Association for Cancer Research invites proposals for its AACR-Bristol Myers Midcareer Female Investigator Grant, a joint effort of the organization and drug company to encourage and support mid-career female physician-scientists and researchers conducting immuno-oncology research and foster their career advancement on the road to becoming a senior investigator.
Through the program, a single grant of up to $225,000 over three years will be awarded in support of a research project focused on immuno-oncology. Projects applying for grant support may be translational and/or clinical in nature.
To be eligible, applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants must also have received their first NIH R01 (or equivalent) award within the past ten years (i.e., the grant cannot have been awarded before July 1, 2011). At the start of the grant term on July 1, 2021, applicants must hold an appointment at the level of associate professor but may work at an academic, medical, or research institution anywhere in the world.
See the American Association for Cancer Research website for complete program guidelines and application instructions.